肉桂穴位贴敷联合塞来昔布胶囊治疗急性痛风性关节炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R589.7

基金项目:


Clinical Study on Point Application with Cinnamomi Cortex Combined with Celecoxib Capsules for Acute Gouty Arthritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察肉桂穴位贴敷联合塞来昔布胶囊治疗风寒湿痹型急性痛风性关节炎的临床疗效。方 法:选取106 例风寒湿痹型急性痛风性关节炎患者,按随机数字表法分为对照组和观察组各53 例。对照组给 予塞来昔布胶囊口服,观察组在对照组基础上加用肉桂穴位贴敷,2 组均治疗14 d。评价2 组临床疗效,比较 2 组治疗前后中医证候积分、关节疼痛及肿胀评分及血沉(ESR)、血尿酸(BUA)、超敏C-反应蛋白(hs-CRP)、 白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α) 水平,并观察不良反应发生情 况。结果:观察组总有效率为92.45%,高于对照组75.47%,差异有统计学意义(P<0.05)。治疗后,2 组中 医证候积分、关节疼痛评分及关节肿胀评分较治疗前降低(P<0.05);且观察组中医证候积分、关节疼痛评分 及关节肿胀评分低于对照组(P<0.05)。治疗后,2 组ESR、BUA、hs-CRP、IL-1β、IL-6、TNF-α 水平较 治疗前降低(P<0.05);且观察组ESR、BUA、hs-CRP、IL-1β、IL-6、TNF-α 水平低于对照组(P<0.05)。 2 组比较不良反应发生率,差异无统计学意义(P>0.05)。结论:肉桂穴位贴敷联合塞来昔布胶囊治疗风寒湿 痹型急性痛风性关节炎可以通过调节机体炎症反应,提高临床疗效,改善临床症状,安全性良好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of point application with Cinnamomi Cortex combined with Celecoxib Capsules for acute gouty arthritis of wind- cold- dampness impediment type. Methods:A total of 106 cases of patients with acute gouty arthritis of wind- cold- dampness impediment type were selected and divided into the control group and the observation group according to the random number table method,with 53 cases in each group. The control group was given the oral administration of Celecoxib Capsules, and the observation group was additionally treated with point application with Cinnamomi Cortex based on the treatment of the control group. Both groups were treated for 14 days. The clinical effects in the two groups were evaluated. Before and after treatment,traditional Chinese medicine (TCM) syndrome scores, scores of joint pain and swelling, erythrocyte sedimentation rate (ESR), blood uric acid (BUA),hypersensitive C-reactive protein (hs-CRP),interleukin-1β (IL-1β),interleukin-6 (IL-6), and tumor necrosis factor- α (TNF- α) were compared between the two groups. The incidence of adverse reactions was observed. Results: The total effective rate was 92.45% in the observation group, higher than that of 75.47% in the control group,the difference being significant (P<0.05). After treatment,TCM syndrome scores, joint pain scores, and joint swelling scores in the two groups were decreased when compared with those before treatment (P<0.05); TCM syndrome score, joint pain score, and joint swelling score in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of ESR, BUA, hs- CRP, IL- 1β, IL- 6, and TNF- α in the two groups were decreased when compared with those before treatment (P<0.05); the levels of ESR, BUA, hs- CRP, IL- 1β,IL- 6,and TNF- α in the observation group were lower than those in the control group (P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Point application with Cinnamomi Cortex combined with Celecoxib Capsules for acute gouty arthritis of wind-cold-dampness impediment type can improve clinical effects and clinical symptoms by regulating the inflammatory response of the body,with good safety.

    参考文献
    相似文献
    引证文献
引用本文

陈宝军,吴玮芳,杨笑颖.肉桂穴位贴敷联合塞来昔布胶囊治疗急性痛风性关节炎临床研究[J].新中医,2023,55(13):175-179

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-07-14
  • 出版日期:
文章二维码